Mar 01, 2016
2:1
For every share held, investors received 2. The price per share adjusted from $19.17 to $9.59.
The split itself did not change the total investment value.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A (SZSE:002099) operates in the Pharmaceuticals: major industry.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A company overviewZhejiang Hisoar Pharmaceutical Co., Ltd. Class A's most recent stock split was on March 1, 2016. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A (SZSE:002099) has split its stock 3 times: a 3-for-2 split on May 29, 2007, a 2-for-1 split on May 22, 2012, and a 2-for-1 split on March 1, 2016.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between May 29, 2007 and March 1, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A's 2-for-1 split on March 1, 2016, every share became 2 shares.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on March 1, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:002099 split will appear on this page.
Already premium?